Search Results 1-10 of 11397 for anti-TNF drugs

  1. Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD

    Approved in 1998 for use in treating Crohn's disease and subsequently in 2005 for treating ulcerative colitis, anti-tumor necrosis factor (TNF) agents have ...

  2. Clinical Outcomes Of Medications Post Anti-TNF: Researching Effectiveness In Pediatric IBD

    The purpose of this study is to compare the effectiveness of specific therapies to treat children with CD and UC/IBD-U refractory to anti-TNF therapy.

  3. Study To Determine Risk Factors For Post-operative Infection In Inflammatory Bowel Disease - Mayo Clinic

    However, many CD and UC patients still ultimately require surgery despite the use of these medications. Side effects of the anti-TNF agents include increased ...

  4. Study To Determine Risk Factors For Post-operative Infection In Inflammatory Bowel Disease - Mayo Clinic

    However, many CD and UC patients still ultimately require surgery despite the use of these medications. Side effects of the anti-TNF agents include increased ...

  5. Adalimumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Psoriatic arthritis usually occurs with a skin condition called psoriasis. Adalimumab may be used alone or in combination with medicines (eg, methotrexate or ...

  6. Ulcerative Colitis Clinical Trials

    ... medications such as the anti-Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ...

  7. Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

    Within the United States, four anti-TNF agents are currently approved for the treatment of IBD — infliximab, adalimumab, certolizumab pegol and golimumab.

  8. Mayo Clinic Researchers: TNF Inhibitors May Increase Cancer Risk in the Eye

    In one of the balancing acts of medicine, the anti-inflammatory action of the drug also increases the risk for other conditions, in this case, a rare form of ...

  9. Transcriptomic Changes Before And After Anti-tnf Therapy Utilizing Optimum Therapeutic Drug Levels - Mayo Clinic

    The purpose of this study is to evaluate infliximab drug levels and anti-infliximab antibody levels in HiSCR50/IHS4 responders versus non-responders at week 18.

  10. Crohn's Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine whether adding low dose methotrexate to anti -TNF therapy is more effective than treatment with anti-TNF therapy alone ...